Patents by Inventor Daiki Kaneko
Daiki Kaneko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11866281Abstract: Provided is an electrostatic adsorption body capable of exhibiting a high adsorption force, especially with respect to a highly insulative sheet-like object to be adsorbed, such as a cloth, while using an electrical adsorption force. This electrostatic adsorption body, which uses electrostatic force to adsorb an object to be adsorbed, is provided with: a laminate sheet in which a 20-200 ?m-thick insulator, a 1-20 ?m-thick electrode layer, and a 20-200 ?m-thick resin film are sequentially laminated; and a power supply device that applies a voltage to the electrode layer, wherein the resin film at least has a tensile modulus of 1 MPa or more and less than 100 MPa and a volume resistivity of 1×1010-1013 ? cm, the electrode layer is composed of a bipolar electrode including a positive electrode and a negative electrode, and an object to be adsorbed is adsorbed using the resin film as an adsorption surface due to an electrostatic adsorption force that is generated by applying a voltage to the electrode layer.Type: GrantFiled: August 1, 2019Date of Patent: January 9, 2024Assignee: CREATIVE TECHNOLOGY CORPORATIONInventors: Daiki Kaneko, Yoshiaki Tatsumi, Shinsuke Hirano
-
Publication number: 20230390399Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 end having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1.000 s?1, as measured.Type: ApplicationFiled: December 30, 2022Publication date: December 7, 2023Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki KANEKO, Takakuni MATSUDA, Yusuke HOSHIKA
-
Patent number: 11638757Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: GrantFiled: August 4, 2021Date of Patent: May 2, 2023Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Daiki Kaneko, Takakuni Matsuda, Yusuke Hoshika
-
Publication number: 20220096638Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: ApplicationFiled: August 4, 2021Publication date: March 31, 2022Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki KANEKO, Takakuni MATSUDA, Yusuke HOSHIKA
-
Publication number: 20210300698Abstract: Provided is an electrostatic adsorption body capable of exhibiting a high adsorption force, especially with respect to a highly insulative sheet-like object to be adsorbed, such as a cloth, while using an electrical adsorption force. This electrostatic adsorption body, which uses electrostatic force to adsorb an object to be adsorbed, is provided with: a laminate sheet in which a 20-200 ?m-thick insulator, a 1-20 ?m-thick electrode layer, and a 20-200 ?m-thick resin film are sequentially laminated; and a power supply device that applies a voltage to the electrode layer, wherein the resin film at least has a tensile modulus of 1 MPa or more and less than 100 MPa and a volume resistivity of 1×1010-1013 ? cm, the electrode layer is composed of a bipolar electrode including a positive electrode and a negative electrode, and an object to be adsorbed is adsorbed using the resin film as an adsorption surface due to an electrostatic adsorption force that is generated by applying a voltage to the electrode layer.Type: ApplicationFiled: August 1, 2019Publication date: September 30, 2021Applicant: CREATIVE TECHNOLOGY CORPORATIONInventors: Daiki KANEKO, Yoshiaki TATSUMI, Shinsuke HIRANO
-
Patent number: 11097007Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: GrantFiled: December 1, 2020Date of Patent: August 24, 2021Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki Kaneko, Takakuni Matsuda, Yusuke Hoshika
-
Publication number: 20210085794Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: ApplicationFiled: December 1, 2020Publication date: March 25, 2021Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki KANEKO, Takakuni MATSUDA, Yusuke HOSHIKA
-
Publication number: 20210038154Abstract: Provided is an attachment pad that can be attached to and held on an attachment target substance such as human skin by an electrical attachment force. An attachment pad, which is used in a state of being attached to an attachment target substance, includes: a laminate sheet in which a first resin film having a thickness of 20 to 200 ?m, an electrode layer having a thickness of 1 to 20 ?m, and a second resin film having a thickness of 20 to 200 ?m are sequentially laminated; and a power supply device for applying a voltage to the electrode layer, wherein at least the second resin film has a tensile elastic modulus of 1 MPa or more and less than 100 MPa and a volume resistivity of 1×1010 to 1×1013 ?·cm, and the attachment pad is attached to the attachment target substance onto one surface of the second resin film as an attachment surface by an electrical attachment force generated by voltage application to the electrode layer.Type: ApplicationFiled: March 14, 2019Publication date: February 11, 2021Applicant: CREATIVE TECHNOLOGY CORPORATIONInventors: Yoshiaki TATSUMI, Shinsuke HIRANO, Kazuki TSUBOI, Daiki KANEKO
-
Publication number: 20200179517Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: ApplicationFiled: February 7, 2020Publication date: June 11, 2020Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki KANEKO, Takakuni MATSUDA, Yusuke HOSHIKA
-
Patent number: 10517951Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: GrantFiled: October 10, 2018Date of Patent: December 31, 2019Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki Kaneko, Takakuni Matsuda, Yusuke Hoshika
-
Publication number: 20190336607Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: ApplicationFiled: July 17, 2019Publication date: November 7, 2019Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki KANEKO, Takakuni MATSUDA, Yusuke HOSHIKA
-
Publication number: 20190099494Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: ApplicationFiled: October 10, 2018Publication date: April 4, 2019Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki KANEKO, Takakuni MATSUDA, Yusuke HOSHIKA
-
Publication number: 20180055941Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: ApplicationFiled: September 11, 2017Publication date: March 1, 2018Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki KANEKO, Takakuni MATSUDA, Yusuke HOSHIKA
-
Injectable depot formulation comprising optically active tolvaptan and process of producing the same
Patent number: 9597283Abstract: This invention provides an injectable formulation to be administered intramuscularly or subcutaneously that is used for the prevention or treatment of polycystic kidney disease, and that can maintain a therapeutically effective blood concentration of tolvaptan for a long period of time; and a process for producing the same. More specifically, this invention relates to an injectable depot formulation comprising (1) a particle containing optically active tolvaptan as an active ingredient and (2) a pharmaceutically acceptable carrier for injection, and a process for producing the same.Type: GrantFiled: December 27, 2013Date of Patent: March 21, 2017Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Daiki Kaneko, Takakuni Matsuda, Kenichi Miyata, Kai Suzuki, Hiroyuki Fujiki, Shizuo Kinoshita, Koji Ohmoto, Miki Aihara -
Publication number: 20160250222Abstract: The present invention provides a combined drug for an injectable depot formulation having a superior effect of preventing and/or treating polycystic kidney disease. More specifically, the present invention relates to a drug for preventing and/or treating polycystic kidney disease, which is an injectable depot formulation comprising a particle containing tolvaptan or a prodrug thereof and a somatostatin analogue. The present invention also relates to a method for preventing and/or treating polycystic kidney disease using the drug.Type: ApplicationFiled: October 14, 2014Publication date: September 1, 2016Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Hiroyuki FUJIKI, Miki AIHARA, Katsuji HATTORI, Koji OHMOTO, Takakuni MATSUDA, Daiki KANEKO
-
INJECTABLE DEPOT FORMULATION COMPRISING OPTICALLY ACTIVE TOLVAPTAN AND PROCESS OF PRODUCING THE SAME
Publication number: 20150352041Abstract: This invention provides an injectable formulation to be administered intramuscularly or subcutaneously that is used for the prevention or treatment of polycystic kidney disease, and that can maintain a therapeutically effective blood concentration of tolvaptan for a long period of time; and a process for producing the same. More specifically, this invention relates to an injectable depot formulation comprising (1) a particle containing optically active tolvaptan as an active ingredient and (2) a pharmaceutically acceptable carrier for injection, and a process for producing the same.Type: ApplicationFiled: December 27, 2013Publication date: December 10, 2015Inventors: Daiki KANEKO, Takakuni MATSUDA, Kenichi MIYATA, Kai SUZUKI, Hiroyuki FUJIKI, Shizuo KINOSHITA, Koji OHMOTO, Miki AIHARA -
Publication number: 20150093442Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.Type: ApplicationFiled: April 23, 2013Publication date: April 2, 2015Inventors: Daiki Kaneko, Takakuni Matsuda, Yusuke Hoshika